Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Solid and crystalline ibandronate sodium and processes for preparation thereof

A technology of sodium ibandronate and crystal form, applied in the field of solid state chemistry of sodium ibandronate, can solve the problems of restricting oral active ingredients and the like

Inactive Publication Date: 2007-08-22
TEVA PHARMA IND LTD
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The rate at which an active ingredient dissolves in a patient's gastric fluid may be of therapeutic interest because it limits the upper limit of the rate at which an orally administered active ingredient can reach the patient's bloodstream

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Solid and crystalline ibandronate sodium and processes for preparation thereof
  • Solid and crystalline ibandronate sodium and processes for preparation thereof
  • Solid and crystalline ibandronate sodium and processes for preparation thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0187] Sodium ibandronate (3 g) was dissolved in dimethylsulfoxide (DMSO) (20 mL) at 125°C. To the resulting solution was added dropwise 2-butanol (40 mL) to give a white precipitate. The slurry was stirred at 125°C for 3 hours, then cooled to room temperature and stirred for 16 hours. The precipitate was separated by vacuum filtration, washed with 2-butanol (2×5 ml), and dried in a vacuum oven at 50° C. for 24 hours to obtain 3 g of sodium ibandronate in crystal form C. Form C ibandronate sodium was analyzed by TGA as described above, and the weight loss was about 15% to about 16%.

Embodiment 2

[0189] Sodium ibandronate (3 g) was dissolved in DMSO (20 mL) at 120°C. To the resulting solution was added dropwise 1-butanol (40 mL) to give a white precipitate. The slurry was stirred at 120°C for 3 hours, then cooled to room temperature and stirred for 16 hours. The precipitate was isolated by vacuum filtration, washed with 1-butanol (2×5 ml), and dried in a vacuum oven at 50° C. for 24 hours to obtain 3 g of sodium ibandronate in crystal form C.

[0190] Sodium Ibandronate Form D

Embodiment 3

[0192] Sodium ibandronate (3 g) was dissolved in water (6 mL) at reflux temperature. To the resulting solution was added dropwise acetone (50 mL) at reflux temperature to obtain a white precipitate. The slurry was stirred at reflux temperature for 4.5 hours, then cooled to room temperature. The precipitate was separated by vacuum filtration, washed with acetone (3×13 ml), and dried in a vacuum oven at 50° C. for 22 hours to obtain 3.3 g of ibandronate sodium ibandronate in crystal form D. D-type ibandronate sodium was analyzed by TGA, and the weight loss was about 25%.

[0193] Sodium Ibandronate Form E

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to solid amorphous and crystalline forms of ibandronate sodium.

Description

[0001] This application claims the benefit of US Provisional Patent Application No. 60 / 604,026, filed August 23, 2004 and Provisional Application No. 60 / 690,867, filed June 16, 2005. technical field [0002] The present invention relates to the solid state chemistry of ibandronate sodium. Background technique [0003] The experimental formula for ibandronate sodium is C 9 h 22 NO 7 P 2 Na·H 2 O. The chemical name of ibandronate sodium is (1-hydroxy-3-(N-methyl-N-pentylamino)propylene) bisphosphonic acid monosodium salt. The chemical structure of ibandronate sodium is as follows: [0004] The chemical structure of ibandronic acid (IBD-Ac) is as follows: [0005] Sodium ibandronate is a third-generation nitrogen-containing bisphosphonate characterized by aliphatic tertiary amine side chains. Ibandronate sodium is a white powder. [0006] US Patent No. 4,972,814 discloses bisphosphonic acid derivatives, methods for their preparation and pharmaceutical compositions ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/663A61P19/10C07F9/38
CPCC07F9/3873A61P19/08A61P19/10A61P3/00A61P35/00A61K31/663
Inventor R·利夫什茨-利伦T·拜尔J·阿伦希姆
Owner TEVA PHARMA IND LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com